Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ragnheidur H Fridriksdottir"'
Autor:
Bryndis Sigurdardottir, Magnus Gottfredsson, Arthur Löve, Ottar M. Bergmann, Ragnheidur H Fridriksdottir, Margaret Hellard, Ubaldo Benitez Hernandez, Gudrun E Baldvinsdottir, Sigurdur Olafsson, Thorolfur Gudnason, Maria Heimisdottir, Thorvardur Jon Love, Valgerdur Runarsdottir, Thorarinn Tyrfingsson, Ingunn Hansdottir, Einar S. Bjornsson, Birgir Johannsson
Publikováno v:
The Lancet Gastroenterology & Hepatology. 6:628-637
Summary Background WHO has set targets to eliminate hepatitis C virus (HCV) infection as a global health threat by 2030 through a 65% reduction in HCV-related deaths and 80% reduction in HCV incidence. To achieve these goals, WHO set service coverage
Autor:
Jon M, Johannesson, Ragnheidur H, Fridriksdottir, Thorvardur J, Löve, Valgerdur, Runarsdottir, Ingunn, Hansdóttir, Arthur, Löve, Marianna, Thordardottir, Ubaldo B, Hernandez, Sigurdur, Olafsson, Magnus, Gottfredsson, Asdis M, Finnbogadottir
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(10)
Background The Treatment as Prevention for Hepatitis C program started in 2016 in Iceland, offering treatment with direct-acting antivirals to hepatitis C virus (HCV)-infected individuals. Reinfections through injection drug use (IDU) can hamper elim
Autor:
Magnús Gottfredsson, Valgerdur Runarsdottir, Thorvardur J. Löve, Ragnheidur H. Fridriksdottir, Thorarinn Tyrfingsson, Ingunn Hansdottir, Ottar M. Bergmann, Einar S. Björnsson, Birgir Johannsson, Bryndis Sigurdardottir, Arthur Löve, Guðrún Erna Baldvinsdóttir, Marianna Thordardottir, Ubaldo Benitez Hernandez, Maria Heimisdottir, Sigurdur Olafsson
Publikováno v:
Journal of Hepatology. 77:S573
Autor:
Jon M Johannesson, Sigurdur Olafsson, Ragnheidur H. Fridriksdottir, Thorvardur J. Löve, Valgerdur Runarsdottir, Gudrun Sigmundsdottir, Arthur Löve, Magnús Gottfredsson
Publikováno v:
Journal of Hepatology. 73:S615
Autor:
Sigurdur Olafsson, Thorvardur J. Löve, Ragnheidur H. Fridriksdottir, Thorarinn Tyrfingsson, Valgerdur Runarsdottir, Ingunn Hansdottir, Ottar M. Bergmann, Einar S. Björnsson, Birgir Johannsson, Bryndis Sigurdardottir, Arthur Löve, Guðrún Erna Baldvinsdóttir, Gudrun Sigmundsdottir, Ubaldo Benitez Hernandez, Maria Heimisdottir, Magnús Gottfredsson
Publikováno v:
Journal of Hepatology. 73:S827
Autor:
Bryndis Sigurdardottir, Arthur Löve, Thorvardur Jon Love, Magnus Gottfredsson, Ottar M. Bergmann, Thorarinn Tyrfingsson, Einar Bjornsson, Sigurdur Olafsson, Gudrun Sigmundsdottir, Birgir Johannsson, Valgerdur Runarsdottir, Ragnheidur H Fridriksdottir
Publikováno v:
Open Forum Infectious Diseases
Background The main driver of the Hepatitis C virus (HCV) epidemic in most western countries is injection drug use (IDU) among people who inject drugs (PWID). Iceland has provided unrestricted access to direct-acting antiviral agents (DAA) to all HCV
Autor:
Ragnheidur H Fridriksdottir, Gudrun Sigmundsdottir, Birgir Johannsson, Ingunn Hansdottir, Einar Bjornsson, Ubaldo Benitez Hernandez, Ottar M. Bergmann, Bryndis Sigurdardottir, Magnus Gottfredsson, Arthur Löve, Thorvardur Jon Love, Thorarinn Tyrfingsson, Sigurdur Olafsson, Maria Heimisdottir, Kamilla S Josefsdottir, Valgerdur Runarsdottir
Publikováno v:
Journal of Hepatology. 70:e337-e338
Autor:
Kamilla S Josefsdottir, Sigurdur Olafsson, Bryndis Sigurdardottir, Arthur Löve, Ottar M. Bergmann, Einar Bjornsson, Magnus Gottfredsson, Ragnheidur H Fridriksdottir, Ubaldo Benitez Hernandez, Thorvardur Jon Love, Valgerdur Runarsdottir, Thorarinn Tyrfingsson, Ingunn Hansdottir, Gudrun Sigmundsdottir, Birgir Johannsson, Maria Heimisdottir
Publikováno v:
Journal of Hepatology. 70:e43
Autor:
Sigurdur Olafsson, Ragnheidur H Fridriksdottir, Valgerdur Runarsdottir, Ottar M. Bergmann, Ubaldo Benitez Hernandez, Magnus Gottfredsson, Ingunn Hansdottir, Bryndis Sigurdardottir, Arthur Löve, Einar Bjornsson, Thorarinn Tyrfingsson, Gudrun Sigmundsdottir, Birgir Johannsson, Maria Heimisdottir, Thorvardur Jon Love
Publikováno v:
Open Forum Infectious Diseases
Background Hepatitis C Virus (HCV) commonly affects people who inject drugs (PWID) and/or with history of injection drug use (IDU). They are also disproportionately represented in addiction treatment centers and the penitentiary system. In order to c
Autor:
Maria Heimisdottir, Bryndis Sigurdardottir, Thorvardur Jon Love, Valgerdur Runarsdottir, Thorarinn Tyrfingsson, Arthur Löve, Gudrun Sigmundsdottir, Birgir Johannsson, Sigurdur Olafsson, Ottar M. Bergmann, Einar Bjornsson, Magnus Gottfredsson, Ragnheidur H Fridriksdottir
Publikováno v:
Open Forum Infectious Diseases
Background Hepatitis C virus (HCV) infection is associated with significant morbidity and mortality. Iceland, an island with a population of 330,000 has a HCV seroprevalence of 0.3% and an estimated total of 800–1000 patients. There is good access